Kim Forest Competitors and Similar CompaniesClear all

Lutonix's competitors and similar companies include Intra-Cellular Therapies and Pharmanutra.

	Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.	Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.	Pharmanutra Pharmanutra, a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices.
Founding Date	Founding Date 2007	Founding Date 2002	Founding Date 2003
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech distribution drug development medical devices pharma
Locations	Locations Maple Grove, US HQ	Locations New York, US HQ	Locations Pisa, IT HQ Pisa, IT
Employees	Employees 10	Employees 330352% increase	Employees 118
Valuation ($)	Valuation ($) N/A	Valuation ($) 8.1 b	Valuation ($) 589.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $680.9m (FY, 2024)	Revenue (est.) €115.5m (FY, 2024)
Net income	Net income N/A	Net income ($74.7m) (FY, 2024)	Net income €16.6m (FY, 2024)
Funding
Total funding raised	Total funding raised $ 35m	Total funding raised $ 225.3m	Total funding raised N/A